Sweden: Chordate Medical plans rights issue to see it through next year

Nasdaq First North listed Chordate Medical plans to carry out an issue of shares with preferential rights amounting to approximately SEK51.3m (US$4.8m) The rights issue is supported by subscription undertakings from main shareholders and members of the board and management corresponding to approximately 33 percent of the transaction. Chordate Medical develops, sells and markets KOS (Kinetic…

You must be a HMI Subscriber to view this content.

Subscribe Now »